Clinical trial
Graft vs Host Disease Prophylaxis in Unrelated Donor Transplantation: a Randomized Clinical Trial Comparing PTCY vs ATG (GRAPPA)
NCT05153226 is registered in ClinicalTrials.gov with DKMS gemeinnützige GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Graft vs Host Disease Prophylaxis in Unrelated Donor Transplantation: a Randomized Clinical Trial Comparing PTCY vs ATG (GRAPPA)
- Lead sponsor
- DKMS gemeinnützige GmbH
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- March 2, 2022
- Completion date
- December 31, 2027
- Enrollment
- 640 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
aml, cmml, graft vs host disease, mds, mds/mpn, peripheral blood stem cell transplantation